Ikić Matijašević, M.; Kilić, P.; Ikić, L.; Galić, I.; Brzović Šarić, V.; Galić, E.
Rituximab, Intravitreal Bevacizumab and Laser Photocoagulation for Treatment of Macrophage Activation Syndrome and Retinal Vasculitis in Lupus: A Case Report. Int. J. Mol. Sci. 2023, 24, 2594.
https://doi.org/10.3390/ijms24032594
AMA Style
Ikić Matijašević M, Kilić P, Ikić L, Galić I, Brzović Šarić V, Galić E.
Rituximab, Intravitreal Bevacizumab and Laser Photocoagulation for Treatment of Macrophage Activation Syndrome and Retinal Vasculitis in Lupus: A Case Report. International Journal of Molecular Sciences. 2023; 24(3):2594.
https://doi.org/10.3390/ijms24032594
Chicago/Turabian Style
Ikić Matijašević, Marina, Paula Kilić, Lucija Ikić, Iva Galić, Vlatka Brzović Šarić, and Edvard Galić.
2023. "Rituximab, Intravitreal Bevacizumab and Laser Photocoagulation for Treatment of Macrophage Activation Syndrome and Retinal Vasculitis in Lupus: A Case Report" International Journal of Molecular Sciences 24, no. 3: 2594.
https://doi.org/10.3390/ijms24032594
APA Style
Ikić Matijašević, M., Kilić, P., Ikić, L., Galić, I., Brzović Šarić, V., & Galić, E.
(2023). Rituximab, Intravitreal Bevacizumab and Laser Photocoagulation for Treatment of Macrophage Activation Syndrome and Retinal Vasculitis in Lupus: A Case Report. International Journal of Molecular Sciences, 24(3), 2594.
https://doi.org/10.3390/ijms24032594
